Early research (Phase 1)Active Not RecruitingNCT05688475What this trial is testingA Rollover Study of CC-122Who this might be right forNon-Hodgkin Lymphoma Bristol-Myers Squibb 12
Not applicableEnded earlyNCT03436771What this trial is testingLong-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell ProductWho this might be right forNon Hodgkin LymphomaMultiple MyelomaChronic Lymphocytic Leukemia+3 more Juno Therapeutics, a Subsidiary of Celgene 4
Not applicableStudy completedNCT00005799What this trial is testingFludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+42 more Fred Hutchinson Cancer Center 55
Early research (Phase 1)Study completedNCT00871663What this trial is testingPhase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6)Who this might be right forSolid TumorsLymphoma, Non-HodgkinMultiple Myeloma+1 more Merck Sharp & Dohme LLC 123
Large-scale testing (Phase 3)Study completedNCT00003204What this trial is testingCombination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Stage III or Stage IV Low-Grade Non-Hodgkin's LymphomaWho this might be right forStage III Grade 1 Follicular LymphomaStage III Grade 2 Follicular LymphomaStage III Grade 3 Follicular Lymphoma+5 more National Cancer Institute (NCI) 515
Large-scale testing (Phase 3)Study completedNCT00003414What this trial is testingGraft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's DiseaseWho this might be right forGraft Versus Host DiseaseLymphoma Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Large-scale testing (Phase 3)UnknownNCT00003337What this trial is testingRadiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's LymphomaWho this might be right forLymphoma Gilead Sciences 100
Testing effectiveness (Phase 2)Study completedNCT02500407What this trial is testingA Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)Who this might be right forLymphocytic Leukemia, ChronicLymphoma, Non Hodgkin Genentech, Inc. 713
Testing effectiveness (Phase 2)WithdrawnNCT00621036What this trial is testingVaccine Therapy and GM-CSF in Treating Patients With CNS LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphomaLymphoproliferative Disorder+1 more University of Texas Southwestern Medical Center
Early research (Phase 1)Study completedNCT02890758What this trial is testingPhase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803Who this might be right forAcute Myeloid LeukemiaMyelodysplastic SyndromeAcute Lymphoblastic Leukemia+11 more Brenda Cooper, MD 14
Early research (Phase 1)Ended earlyNCT05153330What this trial is testingStudy of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLLWho this might be right forAcute Myeloid LeukemiaAcute Lymphoblastic LeukemiaAcute Mixed-Phenotype Leukemia+12 more Biomea Fusion Inc. 55
Testing effectiveness (Phase 2)Study completedNCT00546793What this trial is testingPh I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLLWho this might be right forNHLLymphoma, Non-HodgkinLymphoma, B-Cell+15 more Gilead Sciences 32
Early research (Phase 1)Study completedNCT00049699What this trial is testingVNP40101M in Treating Patients With Advanced or Metastatic CancerWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific Vion Pharmaceuticals
Early research (Phase 1)Study completedNCT00031941What this trial is testingCC-5013 in Treating Patients With Cancer That Has Not Responded to Previous TherapyWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Study completedNCT00416923What this trial is testingIntrathecal Rituximab in Treating Patients With Recurrent CNS LymphomaWho this might be right forBrain and Central Nervous System TumorsLymphoma University of California, San Francisco 10
Testing effectiveness (Phase 2)Study completedNCT00096161What this trial is testingPentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell TransplantWho this might be right forAcute Lymphoblastic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more Fred Hutchinson Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00601718What this trial is testingVorinostat, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Lymphoma or Previously Untreated T-Cell Non-Hodgkin Lymphoma or Mantle Cell LymphomaWho this might be right forAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+34 more University of Washington 29
Testing effectiveness (Phase 2)Study completedNCT01282424What this trial is testingEfficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin LymphomasWho this might be right forFollicular LymphomaSmall Lymphocytic LymphomaLymphoplasmacytic Lymphoma+1 more Gilead Sciences 125
Testing effectiveness (Phase 2)WithdrawnNCT00837174What this trial is testingRelapsed and/or Refractory Non-Hodgkin Lymphoma StudyWho this might be right forNon-Hodgkin Lymphoma The Methodist Hospital Research Institute
Very early researchUnknownNCT04028440What this trial is testingΓδT Cells Immunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)Who this might be right forNon-Hodgkin's LymphomaRelapsed or Refractory B Cell Non-Hodgkin's LymphomaChronic Lymphoblastic Leukemia+1 more Institute of Hematology & Blood Diseases Hospital, China 6